What is a medspa GLP-1 program in Miami, FL?
Put simply, a medspa GLP-1 program turns the weight loss questions your Miami clients already ask into a structured, recurring service. Clients enroll under your medspa’s brand, complete an online health history, and meet a provider licensed in Florida by video, who decides whether semaglutide or tirzepatide is appropriate. Approved prescriptions ship from an FDA-registered 503A or 503B pharmacy, and refills, check-ins and billing run automatically. Telehealth Grow provides the prescribers, protocols, consent templates and EMR, so your aestheticians and front desk can focus on consultations, package sales and complementary treatments like body contouring and skin tightening.
Why Miami is a strong market for a medspa GLP-1 program
With an estimated 489,812 residents (U.S. Census Bureau, 2025), Miami is the 2nd largest city in Florida. It anchors the Miami–Fort Lauderdale–West Palm Beach, FL metropolitan area, a market of about 6,391,072 people.
Since the 2020 Census the city has added roughly 47,571 people, a 10.8% increase that puts Miami among the fastest-growing large cities in the country. New residents are actively choosing new providers, gyms and wellness brands, which creates an opening for a medspa GLP-1 program that establishes its brand early.
At roughly 12,284 people per square mile, Miami is one of the densest cities in the United States. Time-pressed residents tend to prefer a virtual consultation and doorstep delivery over another in-person appointment.
Miami accounts for about 8% of its metro population, and its +10.8% change since 2020 is faster than Florida as a whole (+8.9%). That makes it one of several demand centers in the region, so a telehealth brand that serves the whole metro captures far more patients than a single storefront.
Your patient base can extend well beyond Miami. Within driving distance are Hialeah, FL (8 miles, 231K residents), Miramar, FL (15 miles, 143K residents), Pembroke Pines, FL (18 miles, 177K residents) and Hollywood, FL (18 miles, 157K residents), and telehealth lets one brand serve every one of them.
In Florida, 28.4% of adults were living with obesity in 2020 CDC Behavioral Risk Factor Surveillance System (BRFSS) data — below the median across U.S. states of 31.3%. Applied to Miami’s adult population, that suggests roughly 108,500 adults who could be candidates for a GLP-1 conversation with a licensed provider.
The South and Midwest have the highest adult obesity prevalence of the four U.S. Census regions in CDC data, so demand for medically supervised weight loss here is structural, not a passing trend.
For medspas and aesthetic practices in Miami, that combination of population, health need and telehealth convenience is exactly why a medspa GLP-1 program can build recurring monthly revenue quickly.
| Population (2025 est.) | 489,812 |
|---|---|
| Change since 2020 Census | +10.8% |
| Metro area | Miami–Fort Lauderdale–West Palm Beach, FL (6.4M) |
| Population density | 12,284 per sq mi |
| Adult obesity rate (FL, CDC BRFSS) | 28.4% |
| Estimated adults living with obesity | 108,500 |
| NP practice environment (AANP) | Restricted practice |
Florida compliance snapshot for Miami
A medspa GLP-1 program serving Miami follows Florida law. Three points matter most:
- Prescriber licensure: every patient located in Miami must be treated by a clinician licensed in Florida.
- Nurse practitioner rules: Florida is a restricted practice state in AANP’s classification, which shapes how physician oversight is structured.
- Ownership: the MSO-PC model keeps the business you own separate from the licensed clinical practice.
Read the full Florida medspa GLP-1 program guide for telehealth prescribing, compounding and advertising rules. Our compliance team verifies current requirements for your business during onboarding; this is general information, not legal advice.
Revenue potential in Miami
Here is an illustrative projection. If a medspa GLP-1 program in Miami reached just 0.25% of the adults estimated to be living with obesity, and each active patient generated about $120 in monthly profit (the benchmark used in our revenue calculator), the numbers would look like this:
| Adults living with obesity (est.) | 108,500 |
|---|---|
| Active patients at 0.25% reach | 271 |
| Estimated monthly profit | $32,520 |
| Estimated annual run rate | $390,240 |
Illustration only, not a guarantee. Actual revenue depends on medication costs, dosages, pricing, telehealth visit fees, marketing spend and patient retention.